Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
This study has been completed.
Study NCT00041808 Information provided by FeRx
First Received: July 17, 2002 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastases, Neoplasm
Colorectal Neoplasms
Esophageal Neoplasms
Stomach Neoplasms
Pancreatic Neoplasms
Breast Neoplasms
Melanoma
Sarcoma
Gastrointestinal Neoplasms
Lung Neoplasms
Liver Neoplasms
Cholangiocarcinoma
Additional conditions recognized in this trial
Digestive System Neoplasms
Esophageal Diseases
Neoplasm Metastasis
Neoplasms
More general conditions related to this trial
Adenocarcinoma
Breast Diseases
Carcinoma
Colonic Diseases
Digestive System Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Head and Neck Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Liver Diseases
Lung Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplastic Processes
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Pancreatic Diseases
Pathologic Processes
Rectal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Stomach Diseases
Thoracic Neoplasms
Interventions listed in this trial
MTC-DOX for Injection
Chemotherapy
Additional drug interventions recognized in this trial
Doxorubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
FeRx
Back to top of Main Content
